Bruker (BRKR) Other Non-Current Liabilities (2010 - 2026)
Bruker (BRKR) posted Other Non-Current Liabilities of $609.9 million for Q1 2026, up 1.75% on a QoQ basis from $599.4 million in Q4 2025, and down 7.72% year-over-year from $660.9 million in Q1 2025.
Bruker (BRKR) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Bruker's Other Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $609.9 million for Q1 2026.
- Quarterly Other Non-Current Liabilities fell 7.72% year-over-year to $609.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $609.9 million (down 7.72% YoY) and the FY2025 annual result came in at $599.4 million, up 92.73% from the prior year.
- Other Non-Current Liabilities was $609.9 million for Q1 2026 at Bruker, up from $599.4 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $746.0 million in Q2 2025 and bottomed at $64.4 million in Q4 2023.
- A 5-year average of $399.3 million and a median of $404.5 million in 2023 frame the typical range for Other Non-Current Liabilities.
- Peak annual rise in Other Non-Current Liabilities reached 382.92% in 2024, while the deepest fall reached 57.86% in 2024.
- Bruker's Other Non-Current Liabilities stood at $120.8 million in 2022, then tumbled by 46.69% to $64.4 million in 2023, then surged by 382.92% to $311.0 million in 2024, then jumped by 92.73% to $599.4 million in 2025, then gained by 1.75% to $609.9 million in 2026.
- Business Quant data shows BRKR's Other Non-Current Liabilities at $609.9 million in Q1 2026, $599.4 million in Q4 2025, and $690.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Bruker | 9.46 Bn | 9.50 Bn | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 609.90 Mn |
| Dec 31, 2025 | 599.40 Mn |
| Sep 30, 2025 | 690.20 Mn |
| Jun 30, 2025 | 746.00 Mn |
| Mar 31, 2025 | 660.90 Mn |
| Dec 31, 2024 | 311.00 Mn |
| Sep 30, 2024 | 206.30 Mn |
| Jun 30, 2024 | 178.30 Mn |
| Mar 31, 2024 | 166.70 Mn |
| Dec 31, 2023 | 64.40 Mn |
| Sep 30, 2023 | 404.50 Mn |
| Jun 30, 2023 | 421.00 Mn |
| Mar 31, 2023 | 395.60 Mn |
| Dec 31, 2022 | 120.80 Mn |
| Sep 30, 2022 | 381.80 Mn |
| Jun 30, 2022 | 404.70 Mn |
| Mar 31, 2022 | 426.70 Mn |
| Dec 31, 2021 | 162.20 Mn |
| Sep 30, 2021 | 399.10 Mn |
| Jun 30, 2021 | 395.60 Mn |